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Abstract 
Reports abound on the use and effects of Cannabis sativa. High consumption may result in schizophrenia. It put 
some consumers in a state of coma, while some become unconscious after its consumption. Besides, it restores 
emotional stability in others and fills some consumers with a sense of wellbeing. Epidemiologic data suggest that 
Cannabis sativa use is a serious public health problem because it is highly addictive and is associated with a 
variety of neurological complications. The cerebellum is implicated in locomotor  activity and is richly endowed 
with cannabinoid-1, CB1 receptors; there was the need to assess the microstructure of the cerebellum and to 
evaluate locomotor activity on an animal model  following consumption of Cannabis sativa via various routes of 
administration. Graded doses of various preparations of Cannabis sativa were administered daily for 28 days as 
follows: Group B: 0.41 mg/kg, 0.2 mg/kg, and 0.13 mg/kg body weight of soxtlet extract of Cannabis sativa via 
oral ingestion. Group C: 4grams, 2grams and 1grams of grounded dried leaves of Cannabis sativa via inhalation.  
Group D: A mixture of 8grams, 4grams and 2 grams of grounded dried leaves of Cannabis sativa and 90grams 
of animal feed in each case. Group A served as the control while rats in Group E were given 1gm of 10% Tween 
80 via oral ingestion. Before and after 28 days of administration of Cannabis sativa, the  open field maze and 
Morris water maze experiments on neurobehavioral were carried out. Data were expressed as means ± standard 
error of the mean (M±SEM) and subjected to one way analysis of variance (ANOVA) using PRIMER, EXE, 
version 3.01. Significant difference between means was assessed by Student-Newman-Keuls post hoc test. 95% 
level of significance (P = .05) was used for the statistical analysis; while Microsoft excel 2010 package was used 
for graphs and error bars.  The findings of this study thus suggest that the extract of Cannabis sativa obtained via 
soxtlet extraction technique has a mild and lesser psychoactive effect compared to other preparations of 
Cannabis sativa, thus presents a better method to be adopted in preparation of medical Cannabis.  
Keywords: Cannabis sativa. Cerebellum.  Albino  Wistar rats 
 
1. INTRODUCTION 
Cannabis sativa is the taller variety of Cannabis plant, characterized by narrow serrated leaves and loose spear-
like flower clusters that can be extremely resinous. (www.CannabisDispensary.ca; http://thegreencross.org/why-
cannabis; www.kanducannameds.com). Cannabis sativa, also known as marijuana, pot, reefer, buds, grass, 
weed, ganja, boom, gangster, Mary Jane, sinsemilla, joint, hash oil, and Thai stick, just to mention but a few, 
refers to preparations of the Cannabis plant intended for use as a psychoactive drug and as medicine (Houghton, 
2007 & Fusar-Poli, et al., 2009). 
Some people consume Cannabis sativa for recreational use which is characterized by mild euphoria, 
relaxation, and intensification of ordinary sensory experiences and as a cure to some disease conditions such as 
chronic pain, low blood pressure and alleviation of some undesirable side effects arising from chemotherapy 
treatment of cancer. There is also a wide spread impression that consumption of Cannabis sativa is harmful. 
Cannabis sativa produces a constellation of effects in humans, including alterations in perception and mood, 
intoxication, increased heart rate, physical dependence upon chronic use, and cognitive impairment (Pacher, et 
al., 2006). 
Cannabis has psychoactive and physiological effects when consumed. The minimum amount of THC 
required to have a perceptible psychoactive effect is about 10 micrograms per kilogram of body weight. Aside 
from a subjective change in perception and, most notably, mood, the most common short-term physical and 
neurological effects include increased heart rate, lowered blood pressure, impairment of short-term and working 
memory, psychomotor coordination, and concentration. (Riedel, and Davies,  2005), 
In 2004, the United Nations estimated that global consumption of Cannabis sativa indicated that 
approximately 4.0 percent of the adult world population (162 million people) used Cannabis sativa annually, and 
that approximately 0.6 percent (22.5 million) of people used Cannabis sativa daily. (United Nations Office on 
Drugs and Crime, 2006).  
Since the early 20th century Cannabis sativa has been subject to legal restrictions with the possession, 
use, and sale of Cannabis sativa preparations. The United Nations has found that Cannabis sativa is the most 
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used illicit drug in the world. (World Drug Report 2010; “Cannabis: Legal Status", 2011; Erowid.org.)   
Chemically, the major psychoactive compound in Cannabis sativa is delta-9-tetrahydrocannabinol (∆ 9-
THC); it is one of 400 compounds in the plant, including other cannabinoids, such as cannabidiol (CBD), 
cannabinol (CBN), and tetrahydrocannabivarin (THCV), which can produce sensory effects unlike the 
psychoactive effects of delta-9-tetrahydrocannabinol ( Fusar-Poli, et al. 2009). 
In 2004, the United Nations estimated that global consumption of Cannabis sativa indicated that 
approximately 4.0 percent of the adult world population (162 million people) used Cannabis sativa annually, and 
that approximately 0.6 percent (22.5 million) of people used Cannabis sativa daily. (United Nations Office on 
Drugs and Crime, 2006). 
∆ 9-THC is metabolized mainly to 11-OH-THC (11-hydroxy-THC) by the human body. This 
metabolite is still psychoactive and is further oxidized to 11-Nor-9-carboxy-THC (THC-COOH). In humans and 
animals, more than 100 metabolites could be identified, but 11-OH-THC and THC-COOH are the dominating 
metabolites. Metabolism occurs mainly in the liver by cytochrome P450 enzymes CYP2C9, CYP2C19, and 
CYP3A4. (Geibpraserta, et al, 2009). 
Pathomechanism include excitotoxicity, which may lead to an acute or sub-acute leukoencephalopathy, 
and vascular complications, including vasoconstriction, vasculitis, or hypertension, which may lead to 
intracranial hemorrhage or ischemia. (Geibpraserta, et al, 2009). 
Receptors for THC and other cannabinoid compounds (termed CB1 receptors) and endogenous CB1 
receptor ligands (termed endocannabinoids) are present in the brain, especially in the frontal cortex, basal 
ganglia, cerebellum, and limbic regions. Cannabinoid actions in the basal ganglia and the cerebellum probably 
account for effects on psychomotor control. In humans, Cannabis sativa impairs balance and may induce 
prolonged immobility. (John, 2003). 
Cerebellar damage produces disorders in fine movement, equilibrium, posture and motor learning (Fine, 
Ionita and Lohr, 2002).   
 
1.2. SPECIFIC OBJECTIVES OF THE STUDY 
a. Conduction of neurobehavioral studies for locomotion and exploratory activities on adult albino 
male wistar  rats using open field maze. 
b. Demonstration of the expression of neuron specific enolase (NSE), in the cerebellum of adult 
albino male Wistar rats using immunohistochemical staining method. 
 
2. MATERIALS AND METHODS 
Cannabis sativa was legally obtained from the National Drug Law Enforcement Agency (NDLEA), Akwa Ibom 
State Command, and identified as such by the same agency with a reference code (an equivalent of voucher 
specimen number) NDLEA/AKSC/59/VOL.1/57. 
The dried leaves of Cannabis sativa were grounded and weighed. The extract was obtained via soxlet 
extraction technique and was screened for the presence of alkaloids, saponins, tannins, and cardiac glycoside 
using standard methods (Odebiyi and Sofowora, 1978; Trease and Evans, 1989). 
Determination of LD50 using Lorke’s method. The aim of LD50 study was to ascertain the highest dose 
of Cannabis sativa at which the mice/rat will survive and the lowest dose at which the mice/rat will die; hence, 
the dosage the mice/rat will tolerate. 
Mice were used for this particular study. The mice were sourced from the animal house of the 
Department of pharmacology, Faculty of pharmacy, University of Uyo. Based on the outcome of this study, the 
maximum dosage of the active ingredients of Cannabis sativa that produced 100% mortality was 700mg/kg, 
while the minimum dosage that produced 0% mortality was 600mg/kg. 
LD 50  =  √ AB 
Where: 
A = the maximum dosage that produced 100% mortality 
B = the minimum dosage that produced 0% mortality 
LD 50   =   √ AB       
 =    √600 × 700   
   =    648.07mg/kg 
For the administration of Cannabis sativa to mice, 10%, 20% and 30% of √600 ×700 
(648.07mg/kg) was used.  
Where:  
The value of 10% of 648.07mg/kg = low dose = 64.81mg/kg 
www.iiste.org 
The value 0f 20% of 648.07mg/kg = middle dose = 129.61mg/kg 
The value of 30% of 648.07mg/kg = high dose = 194.42mg/kg 
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10% Tween 80 was the vehicle used to dissolve Cannabis sativa in water.  
10% Tween 80 was prepared by adding 10ml of Tween 80 to 90ml of water. 
The rats for this research were sourced from the animal house of the Faculty of Basic Medical Sciences, 
University of Uyo. Body weight ranging from 200g to 220g was one of the main criteria used for selection. Two 
weeks was allowed for the rats to adapt to their new surroundings. The rats were housed in clean transparent 
cages in a standard animal room. They were fed pelletized rodent diet ad libitum (Vital feeds PLC), and had free 
access to good drinking water. 
A total of fifty (55) adult male albino Wistar rats were used for the research. The rats were divided into 
five groups: A, B, C, D, and E.  
Group A, the control, was made up of five male rats and were given normal clean distilled water.  
Group B, was given the extract of Cannabis sativa via oral ingestion. Group B, comprised of three 
subgroups, namely, B1, B2, and B3. B1 comprising of 5 male rats was given high dose (0.41 mg/kg body 
weight) of Cannabis sativa via oral ingestion. B2 comprising of 5 male rats was given middle dose (0.2 mg/kg 
body weight) of Cannabis sativa via oral ingestion. B3 comprising of 5 male rats was given low dose (0.13 
mg/kg body weight) of Cannabis sativa via oral ingestion. 
Group C, was exposed to smoke from ground dried leaves of Cannabis  Sativa. Group C comprised of 
three subgroups, namely, C1, C2, and C3. This was done by placing red-hot charcoal at the bottom level of a 
desiccator. The required number of grams of dried grounded Cannabis sativa leaves was on each occasion 
spread on top of the red-hot charcoal. Galvanized wire gauze was immediately placed above this compartment to 
separate it from the compartment above it containing the rat and to serve as a platform for the rat. The desiccator 
was covered with its lid once the rat was placed inside, and timing started. The rats were allowed to inhale the 
smoke for three minutes. After every three minutes, the lid was opened for ten seconds to alternate the flow of 
smoke and fresh air to the animals to mimic puffing. C1 comprised of 5 male rats. All  the rats in this group were 
made to inhale (were exposed to ) smoke from 4grams of grounded dried leaves of Cannabis  sativa for three 
minutes; with 10 seconds interval between each   minute to enable them breath in fresh air. C2 comprised of 5 
male rats.  All  the rats in this group were made to inhale (were exposed to ) smoke from 2grams of ground dried 
leaves of Cannabis sativa for three minutes; with 10 seconds interval between each minute to enable them breath 
in fresh air. C3 comprised of 5 male rats.  All  the rats in this group were made to inhale (were exposed to ) 
smoke from 1gram of ground dried leaves of Cannabis sativa for three minutes; with 10 seconds interval 
between each minute to enable them breath in fresh air. 
Group D, was given a mixture of grounded dried leaves of Cannabis sativa and animal feed. Group D, 
comprised of three subgroups, namely, D1, D2, and D3. D1 comprising of 5 male rats were given a mixture 
8grams of grounded dried leaves of Cannabis sativa and 90grams of animal feed. D2 comprising of 5 male rats 
were given a mixture 4grams of grounded dried leaves of Cannabis sativa and 90grams of animal feed. D3 
comprising of 5 male rats were given a mixture 2grams of grounded dried leaves of Cannabis sativa and 90grams 
of animal feed. 
Group E,  has only one group, E. It comprised of 5 male rats. They were given 1gm of 10% Tween 80 
via oral ingestion. 
 
3.STATISTICAL ANALYSIS 
Data were expressed as means ± standard error of the mean (M±SEM) and subjected to one way analysis of 
variance (ANOVA) using PRIMER, EXE, version 3.01. (MacGraw-Hill, 1992). Significant difference between 
means was assessed by Student- Newman-Keuls post hoc test. 95% level of significance (P = .05) was used for 
the statistical analysis; while Microsoft excel 2010 package was used for graphs and error bars.  
 
4. RESULTS.  
4.1. The comparison of frequency of line crossing 
The comparison of frequency of line crossing in open field maze was significantly lowest  (P<0.001) for  the rats 
in group C1, that were made to inhale smoke from 4grams of ground dried Cannabis sativa leaves compared to 
the control group A. The frequency of line crossing in C1 was significantly lower compared to C2, C3 that 
inhaled middle and low doses of Cannabis sativa. The frequency of line crossing in C1 was also lower than other 
experimental groups, namely: B1, B2, B3, and D1, D2, D3, that were given high, middle and low doses of the 
extract of Cannabis sativa via ingestion, and a mixture of feed and grounded dried leaves of Cannabis sativa, 
respectively. The same thing was observed in rats of group E, that was given 10% tween 80. The frequency of 
line crossing was significantly low (P = .05)  in B1, B2, B3, C2, C3, D1, D2, and D3 compared to the control. 
The figures are shown in table 1 below. 
4.1.2.  Comparison of the frequency of rearing  
It was observed that the experimental groups especially those with high and middle doses, namely: B1, B2, C1, 
C2, D1, D2, in addition to B3, C3, D3 were significantly lower (P<0.001) compared to control group A and 
Journal of Natural Sciences Research                                                                                                                                                www.iiste.org 
ISSN 2224-3186 (Paper)   ISSN 2225-0921 (Online) 
Vol.5, No.16, 2015 
 
85 
experimental group E. The result is shown in table 2 below. 
4.1.3. Comparison of the frequency of center square duration 
In the open field, there was no significant difference (P ≤ 0.01) between the experimental groups with respect to 
center square duration. However, the high dose, middle dose and low dose treated subgroups in each group were 
significantly lower (P < 0.05) compared to the control group A and experimental group E that were given 5ml of 
10% Tween 80. 
4.1.4. Comparison of the frequency of stretched attend posture (SAP)   
The frequency of stretched attend posture (SAP) was higher in all the experimental groups compared to the 
control group A and experimental group E. There was no significant difference (P ≤ 0.01) between the control A 
and E.  
Table 1.  Comparison of the frequency of line crossing in the open field 
test following administration of Cannabis sativa(C.S.) 
                           ------------------------------------------------------------------------------------------------ 
                                           Group   Subgroup                   Frequency of line crossing 
   ------------------------------------------------------------------------------------------------- 
           A            A     117.80±1.02 
           B              B1     79.80±0.86* 
                                                                    B2     83.60±1.03* 
                                                                    B3     101.20±1.24*ab 
           C              C1     53.50±1.03*ab 
                                                                    C2     59.40±0.51*ab 
                                                                    C3     59.80±0.58*ab 
            D            D1     72.60±1.12*ab 
                                                                   D2     73.60±1.12*ab 
                                                                   D3     78.40±0.81*b 
            E           E      100.40±3.44*ab 
                          ------------------------------------------------------------------------------------------------ 
   KEY: 
   Values are expressed as mean±standard error of mean (S±SEM). NS = not significant compared to control at 
P=.05. *  = significant compared to control at P=.05. a  = significant compared group 2 at p=0.05. b = significant 
compared group 3 at p=.05  
A  =  control group 
B1 = rats given 0.41mg/kg body weight of soxtlet extract of C.s. via oral ingestion  
B2 = rats given 0.20mg/kg body weight of soxtlet extract of C.s. via oral ingestion 
B3 = rats given 0.13mg/kg body weight of soxtlet extract of C.s. via oral ingestion  
C1 = rats exposed to smoke from 4g of grounded dried leaves of C.s. 
C2 = rats exposed to smoke from 2g of grounded dried leaves of C.s.  
C3 = rats exposed to smoke from 1g of grounded dried leaves of C.s. 
D1 = rats given a mixture of 8g grounded dried leaves of C.s.and 90g of animal feed. 
D2 = rats given a mixture of 4g grounded dried leaves of C.s.and 90g of animal feed. 
D3 = rats given a mixture of 2g grounded dried leaves of C.s.and 90g of animal feed. 
E   = rats given 1gm of 10% Tween 80 via oral ingestion.   
 
  
Journal of Natural Sciences Research                                                                                                                                                www.iiste.org 
ISSN 2224-3186 (Paper)   ISSN 2225-0921 (Online) 
Vol.5, No.16, 2015 
 
86 
Table 2.  Comparison of the frequency of rearing in the open field 
                  test following administration of Cannabis sativa. (C.s.) 
                       ----------------------------------------------------------------------------------------- 
           Group    Subgroup                  Frequency of rearing 
                                   ------------------------------------------------------------------------------------------ 
                  A          A    11.87±0.63 
                  B          B1   10.19±0.01*a 
                 B2   10.37±0.08* 
                 B3   11.91±0.29NSab  
     C         C1    6.22±0.20*abc 
                 C2    6.05±0.14*abc 
                 C3    7.00±0.11*abc 
     D         D1    7.89±0.13*b  
                              D2    9.84±0.13* 
                 D3    10.38±0.10* 
     E         E    12.78±0.34*ab 
                     ----------------------------------------------------------------------------------------- 
Values are expressed as mean±standard error of mean (S±SEM). NS = not significant compared to control at 
P=.05. *  = significant compared to control at P=.05. a  = significant compared group 2 at    p=.05. b  = 
significant compared group 3 at p=0.05.   
               
Table 3.   Comparison of the frequency of center square duration in  
     the open field test following a dministration of Cannabis sativa(C.s.) 
                                    ---------------------------------------------------------------------------------------- 
         Group    Subgroup         Frequency of center square duration  
                      ----------------------------------------------------------------------------------------  
                 A          A   6.60±0.24 
          B             B1  4.60±0.24* 
             B2  5.40±0.24*a 
             B3  5.80±0.20NSabc  
          C              C1  2.20±0.20*abc 
             C2  2.40±0.24*abc 
             C3  2.80±0.37*abc 
         D               D1 4.00±0.32*    
             D2  4.60±0.24* 
             D3  4.80±0.20*a 
      E               E  6.40±0.24NSabc                                                                  
-----------------------------------------------------------------------------------------   
Values are expressed as mean±standard error of mean (S±SEM). NS = not significant compared to control at 
P=.05. *  = significant compared to control at P=.05. a  = significant compared  
group 2 at p=0.05. b  = significant compared group 3 at p=0.05.    
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Table 4 Comparison of the frequency of stretched attend posture  
   (SAP) in the open field test following administration of  
   Cannabis sativa(C.s.) 
           --------------------------------------------------------------------------------------------------- 
   Group  Sub group Stretched attend position  
           --------------------------------------------------------------------------------------------------- 
   A  A  6.00±0.06 
   B  B1  6.40±0.11*ac 
                               B2  6.50±0.08*a 
     B3  6.88±0.03*  
   C  C1  8.90±0.05*ab 
     C2  7.30±0.08*abc 
     C3  8.84±0.17*abc 
   D  D1  6.40±0.06*bc 
     D2  6.70±0.05*bc 
     D3  6.70±0.05*bc 
   E  E  6.08±0.07NSab 
           --------------------------------------------------------------------------------------------------- 
  
Values are expressed as mean±standard error of mean (S±SEM). NS = not significant compared to control at 
P=.05. *  = significant compared to control at P=.05. a  = significant compared to group B1 at p=0.05. b  = 
significant compared to group B2 at p=.05. c  = significant compared to group B3 at p=.05 
 
 
NSE IMMUNOSTAINING METHOD FOR DEMONSTRATION OF NEURONS IN THE 
CEREBELLUM 
(Immunostaining method for neuron specific enolase (NSE). X400). 
        
     
    
PLATE A . Photomicrograph of cross section of the cerebellum of albino rat given distilled water. Group A. 
Section is characterized by  monomorphic population of small-sized purple-colored interneurons (granule 
cells),(nn), and dark stained nuclei(n). (red arrows). Inference: not affected (negatively stained).  
PLATE B. Photomicrograph of cross section of the cerebellum of albino rat given 0.41mg/kg of soxtlet extract 
of Cannabis sativa via oral ingestion. Group B1. Section revealed pyknosis(pkns) of purkinje neurons with 
concurrent swelling and degeneration of the nuclei suggesting karyopyknosis(kpkns). Inference: moderately 
affected ( moderately positive). 
PLATE C. Photomicrograph of cross section of the cerebellum of albino rat given 0.20mg/kg of soxtlet extract 
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of Cannabis sativa via oral ingestion. Group B2. Section is characterized by monomorphic population of small-
sized purple-colored interneurons(nn). The section revealed a single layer of degenerating brown colored 
projection neurons (Purkinje neurons) (Pnn) with karyopyknotic nuclei (kpkn). (red arrows). Inference: slightly 
affected (slightly positive). . 
PLATE D. Photomicrograph of cross section of the cerebellum of albino rat given 0.13mg/kg of soxtlet extract 
of Cannabis sativa via oral ingestion. Group B3. Section is characterized by monomorphic population of small-
sized purple-colored interneurons(nn). The section revealed a single layer of degenerating light-brown colored 
projection neurons (Purkinje neurons) (Pnn) with karyopyknotic nuclei (kpn). (red arrows). Inference: slightly 
affected (slightly positive).  
PLATE E. Photomicrograph of cross section of the cerebellum of albino rat exposed to smoke from 4g of 
grounded dried leaves of Cannabis sativa. Group C1. Section is characterized by classic appearance of complete 
degenerating Purkinje neurons(Pnn) with pyknotic granule cell neurons(pknn) and nuclei(pkn). In addition, there 
is vacuolation(v) within the underlying granule cell layer. Inference: severely affected (strongly positive). 
PLATE F. Photomicrograph of cross section of the cerebellum of albino rat exposed to smoke from 2g of 
grounded dried leaves of Cannabis sativa. Group C2. Section revealed pyknotic Purkinje neurons(pkn) and 
karyopyknotic nuclei(kpkn) in addition to degenerated neurons(dnn) in the overlying molecular layer. Inference: 
severely affected (strongly positive). 
PLATE G. Photomicrograph of cross section of the cerebellum of albino rat exposed to smoke from 1g of 
grounded dried leaves of Cannabis sativa. Group C3. Section revealed pyknotic Purkinje neurons(pkn) and 
karyopyknotic nuclei(kpkn) in addition to degenerated neurons(dnn) in the overlying molecular layer. Inference: 
severely affected (strongly positive). 
PLATE H.  Photomicrograph of cross section of the cerebellum of albino rat  given a mixture 8g of grounded 
dried leaves of Cannabis sativa and 90g of animal feed. Group D1. Section revealed pyknotic Purkinje 
neurons(pkn) and karyorrhexis(krhxs) in addition to degenerated neurons(dnn) in the overlying molecular layer. 
Degeneration occurred in a few granule cell layer neurons(dgnn). Inference: severely affected (strongly positive). 
PLATE I. Photomicrograph of cross section of the cerebellum of albino rat  given a mixture 4g of grounded 
dried leaves of Cannabis sativa and 90g of animal feed. Group D2. Section is characterized by monomorphic 
population of small-sized purple-colored interneurons (granule cells),(nn)  with pyknotic Purkinje neurons(pkn) 
with concurrent swelling and degeneration of the nuclei suggesting karyopyknosis(kpkns). Inference: slightly 
affected ( slightly positive). 
PLATE J. Photomicrograph of cross section of the cerebellum of albino rat  given a mixture 2g of grounded 
dried leaves of Cannabis sativa and 90g of animal feed. Group D3. Section is characterized by monomorphic 
population of small-sized purple-colored interneurons (granule cells),(nn)  with dark stained nuclei(n). (red 
arrows). Inference: not affected (negatively stained).   
PLATE K. Photomicrograph of cross section of the cerebellum of albino rat given 1gm of 10% tween 80. Group 
E. Section is characterized by monomorphic population of small-sized purple-colored interneurons(nn) (granule 
cells), and a single layer of large-sized projection neurons (Purkinje neurons) (Pnn); and dark stained nuclei(n) 
(red arrows). Inference: not affected (negatively stained).  
 
5. DISCUSSION AND CONCLUSION 
In normal adolescents the volume of cerebellar gray matter starts to decrease around puberty and continues until 
early adulthood (Diamond, 2000; Ostby et al, 2009). This increase in gray matter volume in the cerebellum 
replicates results in adults (Cousijn et al, 2012) and in adolescents (Medina et al, 2010). Alterations of this 
phenomenon have been observed in various psychiatric conditions (Mackie et al, 2007) (Jarvis et al, 2008) 
(Castellanos et al, 2002) (Pujol et al, 2004) (Hill et al, 2003) and in adolescents with familiar history of severe 
alcohol abuse (Hill et al, 2007). 
It has been hypothesized that this normal reduction in gray matter volume in the cerebellum is due to 
the pruning of the synaptic connections (Cohen-Cory, 2002). One possible reason for abnormal pruning could be 
the toxic effect of THC at a critical period of brain maturation. Endogenous cannabinoids have an important role 
in synaptic pruning due to their interaction with GB1 receptors controlling the release of glutamate and GABA 
(Bossong and Niesink, 2010). Exogenous cannabinoids might disturb this system by competing for the receptors, 
thus inhibiting the pruning particularly in receptor-rich areas like the cerebellum (Casu et al, 2005) or the 
prefrontal cortex (Bossong and Niesink, 2010). 
Those opposed to Cannabis sativa use substantiated their stand by citing evidence of the personal and 
social harms of Cannabis use. It is unjustifiable to deny the clinical potential of Cannabis sativa. The present 
findings have shown that the Soxhlet extract of Cannabis sativa, compared to other preparations of Cannabis 
sativa, is not likely to produce severe toxicological effects on the central nervous system (cerebellum, with 
respect to this study). Based on these findings, this mode of preparation can be used in the development of 
therapeutic strategies in view of the very low toxicity and the generally benign side effects of this extract.  
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RECOMMENDATION   
This could be regarded as preliminary probes; further research aimed at understanding the real ingredients or 
part(s) of the contents of Cannabis sativa that was either eliminated or destroyed during the Soxhlet extraction 
process may help in the development of therapeutic strategies to prevent or ameliorate Cannabis sativa-induced 
impairments and its disruptive effect on performance in a wide range of animal models of learning and memory. 
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